RSV IMMUNISATION
Clinical trials for RSV IMMUNISATION explained in plain language.
Never miss a new study
Get alerted when new RSV IMMUNISATION trials appear
Sign up with your email to follow new studies for RSV IMMUNISATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
RSV nasal vaccine trial for kids halted – what we know
⭐️ VACCINE ⭐️ TerminatedThis phase 3 study tested an intranasal RSV vaccine in about 6,300 healthy children aged 6 to 22 months. The goal was to see if two doses of the nasal spray could prevent lower respiratory tract infections caused by RSV. The trial was terminated early, so final results are not av…
Matched conditions: RSV IMMUNISATION
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:01 UTC
-
Could a Lower-Dose RSV vaccine protect babies just as well?
⭐️ VACCINE ⭐️ TerminatedThis study tested a nasal spray RSV vaccine in nearly 1,000 healthy infants and toddlers aged 6 to 22 months. The goal was to see if a lower dose works as well as the standard dose and to check safety across different doses. The trial was ended early, so final results are not ava…
Matched conditions: RSV IMMUNISATION
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:01 UTC